CTLA4 and colitis: A study by Wang et al. revealed the important role of Bifidobacteria in reducing the incidence of colitis caused by CTLA4 blockade and found that vancomycin treatment enhanced the safety of colitis in mice treated with DSS + anti-CTLA-4.